Scholars Central

Conference abstractPublished 26 Feb 2018

Stem cells and tissue engineering as emerging therapies in ophthalmology

Authors: Carl M Sheridan

University of Liverpool, United Kingdom

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The eye is a significant focus for advancing regenerative medicine and translational research into human patients. The talk aims to highlight these by addressing tissue-engineering (TE) approaches for the cornea and retina. New cell-based therapies are emerging to repair or replace specific cells within the retina. These techniques are at the forefront of human stem cell research and gene therapy with several phase 1/2 clinical trials currently underway including the first use of iPS cells in human trials. They offer substantial hope for treating numerous retinal diseases such as Age-related Macular Degeneration. In addition corneal diseases have often been successfully treated by allogeneic corneal transplantation, yet supply shortage through human donor eye banks, optical clarity or graft rejection remains a major challenges. Corneal TE research is encompassing scaffolds for stromal and endothelial transplants, optical transparency or in vivo biocompatibility studies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectEngineering
  • SubjectGenetics & Molecular Biology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Carl M Sheridan”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels